Ability of L-carnitine to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Heart Failure
Interventions: DRUG: L-carnitine
Sponsor: Ottawa Heart Institute Research Corporation
Collaborators: Canadian Institutes of Health Research (CIHR)